Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 48,100 shares at $73.15 ($3.6M) on 2023-12-13, disclosed to the SEC on 2023-12-13.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.15 | 3,200 | $234K | 6.5% |
| 2 | $73.15 | 3,200 | $234K | 6.5% |
| 3 | $74.22 | 10,600 | $787K | 21.9% |
| 4 | $75.12 | 13,722 | $1.0M | 28.7% |
| 5 | $75.12 | 13,722 | $1.0M | 28.7% |
| 6 | $75.73 | 1,828 |
| $138K |
| 3.9% |
| 7 | $75.73 | 1,828 | $138K | 3.9% |
| Total | $74.71 avg | 48,100 | $3.6M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |